PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Pfizer (PFE) CEO: Currently Focused on Smaller Deals - Bloomberg
January 29, 2019 10:23 AM ESTPfizer (NYSE: PFE) CEO: Currently Focused on Smaller Deals - Bloomberg
Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus
January 29, 2019 6:46 AM ESTPfizer (NYSE: PFE) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $13.98 billion versus the consensus estimate of $13.91 billion.
GUIDANCE:
Pfizer sees FY2019 EPS of $2.82-$2.92, versus the consensus of $3.04. Pfizer sees... More
